Skip to content
OpenCapital
Get started

Indivior Pharmaceuticals, Inc. INDV Change in AR

Change in AR at other companies

JAN
Janus Living JAN
-$943K-131%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%
Enterprise value$4.86B+242%
P/E18×—
P/S3.5×+2.3×

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Return on equity-117%—
Debt / equity-3.5×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's change in AR?
Indivior Pharmaceuticals, Inc. (INDV) reported change in AR of $20M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's change in AR changed year-over-year?
Indivior Pharmaceuticals, Inc. 's change in AR increased by 281.8% year-over-year, from -$11M to $20M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's change in AR?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's change in AR has grown at a -47.7% compound annual growth rate (CAGR), from $21M to -$3M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.